$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
多吉美治疗期间要注意什么?
2025-10-19 11:44:20
Check Details
仑伐替尼治疗期间的注意事项有什么?
2025-10-19 11:44:20
Check Details
乐伐替尼治什么呢?
2025-10-19 11:44:20
Check Details
仑伐替尼治疗效果好吗?
2025-10-19 11:44:20
Check Details
仑伐替尼中国上市了吗?
2025-10-19 11:44:20
Check Details
仑伐替尼最新中文说明书
2025-10-19 11:44:20
Check Details
用仑伐替尼多久会耐药呢?
2025-10-19 11:44:20
Check Details
乐伐替尼获批的适应症有哪些呢?
2025-10-19 11:44:20
Check Details
乐伐替尼治疗效果好吗?
2025-10-19 11:44:20
Check Details
索拉非尼是什么?
2025-10-19 11:44:20
Check Details
索拉非尼有耐药性吗?
2025-10-19 11:44:20
Check Details
多吉美的适用人群
2025-10-19 11:44:20
Check Details
1
2
...
2673
2674
2675
2676
2677
2678
2679
...
4160
4161
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
2
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
3
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
4
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
5
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
6
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
7
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
8
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
9
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
10
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
11
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
12
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments